Antipsychotics

Around 360,000 patients at risk of being ‘trapped’ on antipsychotics, researchers warn

The British Journal of General Practice's cross-sectional study highlights that between 360,000 and 390,000 patients in the UK could be being prescribed long-term antipsychotics "without regular psychiatric review”.…

Antipsychotic drugs in dementia treatment associated with range of adverse reactions

Experts say the findings suggest that the risks of prescribing antipsychotics in people with dementia “may be more severe than previously understood”.…

Esketamine outperforms quetiapine for treatment-resistant depression, study finds

Patients with treatment-resistant depression, who received esketamine nasal spray plus an antidepressant, were more likely to achieve remission at eight weeks than those who received quetiapine and an antidepressant, according to trial results.…

Pharmacist prescribers can reduce sedative use in care homes, study demonstrates

Researchers found that pharmacist independent prescribers were able to improve outcomes for care home residents through "effective deprescribing" of anticholinergic and sedative drugs.…

Anticholinergic drugs and dementia: a causal link?

The implications of changes to the regulation of oxybutynin in the UK and the case for deprescribing anticholinergics, such as this, to prevent cognitive adverse effects.…

Data show ‘spiralling’ antipsychotic price increases of up to 1,200% in past five years

Exclusive: Analysis of NHS data show that the price of risperidone has increased the most out of all antipsychotics, from £3.09 in July 2017 to £41.16 in June 2022 — an increase of 1,232%.…

The rising price of antipsychotics and what it means

Data analysis has revealed that the drug tariff for some mental health medicines has increased by more than 1,200% as demand has risen.…

Schizophrenia drug shortage affecting patient care, College of Mental Health Pharmacy warns

Supplies of aripiprazole 10mg tablets are low until late August 2022 and there is "limited scope for alternatives".…

Antipsychotic use in people with dementia living in care homes rose during COVID-19 pandemic

Data show the rate of antipsychotic prescribing rose from 18% of people with dementia in care homes before the pandemic to 28% of people during the pandemic.…

Antipsychotics increasingly prescribed for personality disorders, against NICE guidance

Study results have shown that antipsychotics have been prescribed for personality disorders more often and for longer periods of time between 2000 and 2016.…